Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weinstein

Showing results (571-580 of 611) with videos related to

Pageof 62
Sort By:
HIV Medicine|September 1, 2007
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approachY Yazdanpanah, M Vray, J Meynard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapyElena Losina, Bruce R Schackman, Sara N Sadownik, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 17, 2017
Cardiorespiratory Fitness after Transient Ischemic Attack and Minor Ischemic Stroke: Baseline Data of the MoveIT StudyH Myrthe Boss, Inger A Deijle, Sander M Van Schaik, et al.
Journal of the International AIDS Society|January 5, 2023
Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settingsCaitlin M Dugdale, Ogochukwu Ufio, Christopher Alba, et al.
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCIJolene F Leijenaar, Silvia Ingala, Carole H Sudre, et al.
AIDS (London, England)|April 15, 2015
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of ageAndrea L Ciaranello, Kathleen Doherty, Martina Penazzato, et al.
BMJ Open|January 2, 2015
A randomised controlled trial of aerobic exercise after transient ischaemic attack or minor stroke to prevent cognitive decline: the MoveIT study protocolH M Boss, S M Van Schaik, I A Deijle, et al.
AIDS (London, England)|September 25, 2007
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapyKenneth A Freedberg, Nagalingeswaran Kumarasamy, Elena Losina, et al.
Pageof 62

Showing results (571-580 of 611) with videos related to

Sort By:
Pageof 62
HIV Medicine|September 1, 2007
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approachY Yazdanpanah, M Vray, J Meynard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapyElena Losina, Bruce R Schackman, Sara N Sadownik, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 17, 2017
Cardiorespiratory Fitness after Transient Ischemic Attack and Minor Ischemic Stroke: Baseline Data of the MoveIT StudyH Myrthe Boss, Inger A Deijle, Sander M Van Schaik, et al.
Journal of the International AIDS Society|January 5, 2023
Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settingsCaitlin M Dugdale, Ogochukwu Ufio, Christopher Alba, et al.
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
Annals of Internal Medicine|March 31, 2015
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infectionBenjamin P Linas, Devra M Barter, Jake R Morgan, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCIJolene F Leijenaar, Silvia Ingala, Carole H Sudre, et al.
AIDS (London, England)|April 15, 2015
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of ageAndrea L Ciaranello, Kathleen Doherty, Martina Penazzato, et al.
BMJ Open|January 2, 2015
A randomised controlled trial of aerobic exercise after transient ischaemic attack or minor stroke to prevent cognitive decline: the MoveIT study protocolH M Boss, S M Van Schaik, I A Deijle, et al.
AIDS (London, England)|September 25, 2007
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapyKenneth A Freedberg, Nagalingeswaran Kumarasamy, Elena Losina, et al.
Pageof 62